These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18561523)

  • 1. Effect of ramipril on renal function in patients with intermittent claudication.
    Hobbs SD; Claridge MW; Wilmink AB; Adam DJ; Thomas ME; Bradbury AW
    Vasc Health Risk Manag; 2008; 4(2):471-5. PubMed ID: 18561523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a randomized controlled trial. Journal of the American Medical Association 2013; 309: 453-460.
    Kurklinsky AK; Levy M
    Vasc Med; 2013 Aug; 18(4):234-6. PubMed ID: 23867841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.
    Mann JF; Schmieder RE; McQueen M; Dyal L; Schumacher H; Pogue J; Wang X; Maggioni A; Budaj A; Chaithiraphan S; Dickstein K; Keltai M; Metsärinne K; Oto A; Parkhomenko A; Piegas LS; Svendsen TL; Teo KK; Yusuf S;
    Lancet; 2008 Aug; 372(9638):547-53. PubMed ID: 18707986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial.
    Mann JF; Gerstein HC; Pogue J; Bosch J; Yusuf S
    Ann Intern Med; 2001 Apr; 134(8):629-36. PubMed ID: 11304102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brief communication: ramipril markedly improves walking ability in patients with peripheral arterial disease: a randomized trial.
    Ahimastos AA; Lawler A; Reid CM; Blombery PA; Kingwell BA
    Ann Intern Med; 2006 May; 144(9):660-4. PubMed ID: 16670135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Summaries for patients. Ramipril improves walking ability in patients with peripheral arterial disease.
    Ann Intern Med; 2006 May; 144(9):I24. PubMed ID: 16670129
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of angiotensin-converting enzyme inhibitors in patients with heart failure and renal insufficiency: how concerned should we be by the rise in serum creatinine?
    Ahmed A
    J Am Geriatr Soc; 2002 Jul; 50(7):1297-300. PubMed ID: 12133029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of an angiotensin-converting enzyme inhibitor on residual renal function in patients receiving peritoneal dialysis. A randomized, controlled study.
    Li PK; Chow KM; Wong TY; Leung CB; Szeto CC
    Ann Intern Med; 2003 Jul; 139(2):105-12. PubMed ID: 12859160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Ramipril Efficacy in Nephropathy.
    Ruggenenti P; Perna A; Gherardi G; Gaspari F; Benini R; Remuzzi G
    Lancet; 1998 Oct; 352(9136):1252-6. PubMed ID: 9788454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria.
    Ruggenenti P; Perna A; Gherardi G; Garini G; Zoccali C; Salvadori M; Scolari F; Schena FP; Remuzzi G
    Lancet; 1999 Jul; 354(9176):359-64. PubMed ID: 10437863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin-converting enzyme inhibitors for intermittent claudication associated with peripheral arterial disease.
    Hunter MR; Cahoon WD; Lowe DK
    Ann Pharmacother; 2013 Nov; 47(11):1552-7. PubMed ID: 24285767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: results from the ONTARGET trial.
    Heerspink HJ; Gao P; de Zeeuw D; Clase C; Dagenais GR; Sleight P; Lonn E; Teo KT; Yusuf S; Mann JF
    Eur J Prev Cardiol; 2014 Mar; 21(3):299-309. PubMed ID: 24191305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular and renal outcomes with telmisartan, ramipril, or both in people at high renal risk: results from the ONTARGET and TRANSCEND studies.
    Tobe SW; Clase CM; Gao P; McQueen M; Grosshennig A; Wang X; Teo KK; Yusuf S; Mann JF;
    Circulation; 2011 Mar; 123(10):1098-107. PubMed ID: 21357827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive efficacy of olmesartan medoxomil and ramipril in elderly patients with mild to moderate hypertension grouped according to renal function status : a retrospective analysis.
    Malacco E; Omboni S; Mallion JM; Volpe M;
    High Blood Press Cardiovasc Prev; 2012 Dec; 19(4):213-22. PubMed ID: 23430666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ramipril for treatment of intermittent claudication.
    Poredos P
    Vasa; 2013 Jul; 42(4):237-8. PubMed ID: 23823855
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute change in glomerular filtration rate with inhibition of the renin-angiotensin system does not predict subsequent renal and cardiovascular outcomes.
    Clase CM; Barzilay J; Gao P; Smyth A; Schmieder RE; Tobe S; Teo KK; Yusuf S; Mann JF
    Kidney Int; 2017 Mar; 91(3):683-690. PubMed ID: 27927602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a randomized controlled trial.
    Ahimastos AA; Walker PJ; Askew C; Leicht A; Pappas E; Blombery P; Reid CM; Golledge J; Kingwell BA
    JAMA; 2013 Feb; 309(5):453-60. PubMed ID: 23385271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized clinical trial of angiotensin-converting enzyme inhibitor, ramipril, in patients with intermittent claudication.
    Shahin Y; Cockcroft JR; Chetter IC
    Br J Surg; 2013 Aug; 100(9):1154-63. PubMed ID: 23842829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Manipulation of the renin angiotensin system in peripheral arterial disease.
    Hobbs SD; Thomas ME; Bradbury AW
    Eur J Vasc Endovasc Surg; 2004 Dec; 28(6):573-82. PubMed ID: 15531190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential vascular mechanisms of ramipril induced increases in walking ability in patients with intermittent claudication.
    Ahimastos AA; Latouche C; Natoli AK; Reddy-luthmoodoo M; Golledge J; Kingwell BA
    Circ Res; 2014 Mar; 114(7):1144-55. PubMed ID: 24397981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.